Abstract
Challenges in developing therapeutics for Brain Cancer and Central Nervous System (CNS) diseases remain chiefly ascribed to the Blood-Brain Barrier (BBB) since its complex cellular interactions restrict the drug penetration, leading to low treatment effectiveness. Zika Virus (ZIKV) is an oncolytic virus used in virotherapy to selectively target and kill brain Cancer stem-like cells, inclu…